CNBCSquawkBox on Nostr: Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug ...
Novo Nordisk CEO Lars Fruergaard Jørgensen on Q4 results, Wegovy demand and drug pipeline outlook
CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly earnings results, demand for Wegovy, drug pipeline outlook, Cagrisema results, obesity drug pricing, state of Medicare drug price negotiations, and more.
https://www.cnbc.com/video/2025/02/05/novo-nordisk-ceo-lars-fruergaard-jargensen-on-q4-results-wegovy-demand-drug-pipeline-outlook.html
CNBC’s Angelica Peebles and Novo Nordisk CEO Lars Fruergaard Jørgensen join 'Squawk Box' to discuss the company's quarterly earnings results, demand for Wegovy, drug pipeline outlook, Cagrisema results, obesity drug pricing, state of Medicare drug price negotiations, and more.
https://www.cnbc.com/video/2025/02/05/novo-nordisk-ceo-lars-fruergaard-jargensen-on-q4-results-wegovy-demand-drug-pipeline-outlook.html